2 completed, 1 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow IV Iron: new trials by email Literature Review of IV Iron trials Research Report on IV Iron
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA) Ferumoxytol intravenous, Ferrous sulfate - Restless Legs Syndrome, Iron Deficiency Anemia | Phase 2 | Completed | Auerbach Hematology Oncology Associates P C | 100 | 2014-08-01 | 2024-01-30 |
| Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery EPO, Feraheme - Anemia, Cardiovascular Disease | Phase 1 / Phase 2 | Terminated | University of Texas Southwestern Medical Center | 5 | 2013-04-09 | 2020-10-23 |
| Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment Roxadustat, Oral Iron, IV Iron - Dialysis, Anemia | Phase 2 | Completed | Kyntra Bio | 60 | 2011-07-21 | 2021-10-01 |
Anemia (2) · Anemia, Iron-Deficiency (2) · Cardiovascular Diseases (1) · Kidney Failure, Chronic (1) · Restless Legs Syndrome (1)
Auerbach Hematology Oncology Associates P C (1) · Kyntra Bio (1) · University of Texas Southwestern Medical Center (1)
United States (3) · Hong Kong (1) · Russia (1) · Singapore (1)
Michael Auerbach, MD (1) · Philip E. Greilich, MD (1)